Hemostemix (CVE:HEM) Stock Price Crosses Below 50-Day Moving Average of $0.17

Hemostemix Inc. (CVE:HEMGet Rating)’s share price passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of C$0.17 and traded as low as C$0.14. Hemostemix shares last traded at C$0.14, with a volume of 25,500 shares trading hands.

Wall Street Analyst Weigh In

Separately, Fundamental Research set a C$0.96 price target on Hemostemix and gave the company a “buy” rating in a research note on Tuesday, August 30th.

Hemostemix Stock Performance

The firm has a market capitalization of C$10.60 million and a price-to-earnings ratio of -1.14. The company has a 50 day moving average price of C$0.17 and a two-hundred day moving average price of C$0.25.

About Hemostemix

(Get Rating)

Hemostemix Inc, a biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions. The company develops cell therapy products from the patient's own blood, which is a non-invasive source of therapeutic cells. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of critical limb ischemia in Canada and the United States, as well as for the treatment of heart and peripheral arterial diseases.

Recommended Stories

Receive News & Ratings for Hemostemix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemostemix and related companies with MarketBeat.com's FREE daily email newsletter.